Participant-centric study design has advanced, but site-centric execution has not kept pace. In the Journal for Clinical Studies, Brian Mallon examines how unclear expectations, administrative burden and contract delays ...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
COVID-19 vaccine response
James Cummings, President, ICON Government & Public Health Solutions, and Beth Tulip, Vice President, Project Management, Vaccines & Infectious Diseases, discuss developments in vaccine research efforts and key challenges of delivering a coronavirus vaccine.
-
Translation services and the race for a coronavirus vaccine
An article featuring commentary from Adelina Lear regarding the role of language services in the drug development lifecycle.
-
ICON launches Coronavirus Observatory
This article discusses ICON’s Coronavirus Observatory, a tool providing real-time updates on COVID-19 vaccine trials, and insights into key issues.
Read more about ICON's expertise in COVID-19 clinical trials.
-
Role of data in revolutionising the CRO industry
In a wide-ranging interview with PharmaBoardroom, ICON CIO, Tom O’Leary highlights the role of data in revolutionising the CRO industry and the steps that still need to be taken to better match patients with targeted therapies and improve health outcomes.
-
The Significant Role of a Robust Regulatory Intelligence Process in Global Safety Submissions
Pharmacovigilance insights on the efforts towards the international standardisation of electronic transmission of drug safety information to achieve a unified objective of patient safety, written by Arinder Sihota and Trupti Gurjar, which featured in the March 2020 edition of Pharma Focus.
-
Best Practices in Seasonal Vaccine Efficacy Studies: Tips for Successful Planning and Execution
A thought leadership piece by Cindy Dukes exploring the unique challenges in planning and executing a seasonal vaccine study.
-
Is Pharma Finally Heading for Launch Excellence?
The traditional approaches to launching a new medicine still tend to sit in the commercial function, but they need to better align with HEOR, medical affairs and clinical teams. Read more in the February issue of PME.
-
-
Keeping it Real: Challenges and Benefits of Integrating AI and Machine Learning into Pharma R&D
ICON's CIO Tom O'Leary provides expert commentary on integrating AI and machine learning into Pharma R&D in this January 2020 Bio IT World Article.
